Shanghai Bairun Investment Holding Group Co., Ltd. (002568.SZ)
Shanghai, CN
Shanghai Bairun Investment Holding Group Co., Ltd. operates within China, focusing on the complete cycle of flavor and fragrance product development. Under its Bairun brand, the company engages in the research, formulation, manufacturing, and distribution of these products, in addition to providing associated services. Furthermore, the group participates in the ready-to-drink cocktail market. Its extensive range of flavor and fragrance solutions are incorporated into numerous consumer items such as beverages, dairy products, sweets, baked goods, frozen desserts, savory foods, oral care essentials, and tobacco products. Initially established as Shanghai Bairun Flavor & Fragrance Co., Ltd., the firm officially changed its name to Shanghai Bairun Investment Holding Group Co., Ltd. in December 2015. The enterprise was founded in 1997 and its primary base of operations is in Shanghai, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.11% | -4.32% | +4.00% | -11.97% | -28.01% | -17.74% | -29.59% | -53.11% | -71.45% | +58.76% | +318.18% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | -2 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-3.4% Q1'26: +8.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-10.1% Q1'26: +16.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+17.8% ★ Q1'26: -2.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+28.2% ★ Q1'26: +34.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+12.4% ★ Q1'26: +16.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-1.4% ★ Q1'26: +2.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.16× Q1'26: 1.68× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 2 EPS Ana. |
Dec 2027 8 Rev. Ana. 2 EPS Ana. |
Dec 2028 6 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.35B
est: 2.35B (+0.0%)
|
925.42M
est: 935.00M (-1.0%)
|
1.17B
est: 1.20B (-2.1%)
|
1.23B
est: 1.23B (+0.1%)
|
1.47B
est: 1.50B (-2.0%)
|
1.93B
est: 1.93B (-0.1%)
|
2.59B
est: 2.69B (-3.7%)
|
2.59B
est: 2.54B (+2.1%)
|
3.26B
est: 3.41B (-4.4%)
|
3.05B
est: 3.28B (-7.0%)
|
2.94B
est: 3.02B (-2.5%)
|
3.28B
3.15B – 3.38B
+8.5% YoY
|
3.66B
3.17B – 4.95B
+11.7% YoY
|
3.91B
3.56B – 4.70B
+6.8% YoY
|
| EBITDA |
623.69M
est: 795.74M (-21.6%)
|
-208.78M
est: 316.47M (-166.0%)
|
266.13M
est: 404.98M (-34.3%)
|
193.44M
est: 415.98M (-53.5%)
|
417.94M
est: 507.40M (-17.6%)
|
660.97M
est: 653.00M (+1.2%)
|
876.41M
est: 911.68M (-3.9%)
|
762.80M
est: 859.79M (-11.3%)
|
1.17B
est: 1.16B (+1.2%)
|
1.09B
est: 1.13B (-3.3%)
|
1.10B
est: 1.04B (+6.0%)
|
1.13B
1.08B – 1.16B
+8.5% YoY
|
1.26B
1.09B – 1.71B
+11.7% YoY
|
1.35B
1.23B – 1.62B
+6.8% YoY
|
| EBIT |
603.42M
est: 669.71M (-9.9%)
|
-250.84M
est: 266.34M (-194.2%)
|
213.79M
est: 340.83M (-37.3%)
|
120.08M
est: 350.09M (-65.7%)
|
345.79M
est: 427.03M (-19.0%)
|
569.26M
est: 549.57M (+3.6%)
|
774.21M
est: 767.28M (+0.9%)
|
608.21M
est: 723.61M (-15.9%)
|
991.01M
est: 972.50M (+1.9%)
|
890.85M
est: 925.18M (-3.7%)
|
829.80M
est: 852.23M (-2.6%)
|
924.63M
887.49M – 952.65M
+8.5% YoY
|
1.03B
894.44M – 1.40B
+11.7% YoY
|
1.10B
1.00B – 1.33B
+6.8% YoY
|
| Net Income |
500.20M
est: 296.71M (+68.6%)
|
-147.02M
est: -85.08M (-72.8%)
|
182.65M
est: 236.63M (-22.8%)
|
123.76M
est: 116.99M (+5.8%)
|
300.33M
est: 297.78M (+0.9%)
|
535.51M
est: 531.75M (+0.7%)
|
666.06M
est: 774.23M (-14.0%)
|
521.28M
est: 460.65M (+13.2%)
|
809.42M
est: 817.98M (-1.0%)
|
719.14M
est: 765.37M (-6.0%)
|
637.42M
est: 701.77M (-9.2%)
|
741.62M
715.32M – 767.92M
+5.7% YoY
|
852.12M
803.90M – 900.35M
+14.9% YoY
|
942.11M
831.07M – 1.19B
+10.6% YoY
|
| SGA |
1.06B
est: 673.69M (+56.6%)
|
865.93M
est: 267.93M (+223.2%)
|
507.71M
est: 342.86M (+48.1%)
|
597.51M
est: 352.18M (+69.7%)
|
514.75M
est: 429.57M (+19.8%)
|
523.11M
est: 552.84M (-5.4%)
|
698.64M
est: 771.85M (-9.5%)
|
793.19M
est: 727.91M (+9.0%)
|
896.07M
est: 978.29M (-8.4%)
|
949.74M
est: 976.77M (-2.8%)
|
965.90M
est: 899.75M (+7.4%)
|
976.19M
936.98M – 1.01B
+8.5% YoY
|
1.09B
944.32M – 1.47B
+11.7% YoY
|
1.16B
1.06B – 1.40B
+6.8% YoY
|
| EPS |
0.29
est: 0.28 (+1.9%)
|
-0.08
est: -0.08 (+0.0%)
|
0.11
est: 0.23 (-51.6%)
|
0.10
est: 0.11 (-10.9%)
|
0.30
est: 0.29 (+5.0%)
|
0.51
est: 0.51 (0.0%)
|
0.64
est: 0.74 (-13.8%)
|
0.50
est: 0.44 (+13.1%)
|
0.78
est: 0.78 (-0.6%)
|
0.69
est: 0.74 (-7.3%)
|
0.62
est: 0.68 (-9.2%)
|
0.72
0.70 – 0.75
+5.7% YoY
|
0.83
0.78 – 0.88
+14.9% YoY
|
0.92
0.81 – 1.16
+10.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.09% | 32.6K | 0.65% |
| 2 | State Street SPDR S&P Emerging Asia Pacific ETF GMF | 0.01% | 58.6K | 0.49% |
| 3 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.01% | 1.57M | 0.07% |
| 4 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 142.2K | 0.19% |
| 5 | State Street SPDR S&P China ETF GXC | 0.01% | 27.7K | 0.59% |
| 6 | Franklin FTSE China ETF FLCH | 0.01% | 16.8K | 0.19% |
| 7 | Schwab Emerging Markets Equity ETF SCHE | 0.00% | 246.8K | 0.06% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 22.9K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 51.5K | 0.26% |
| 10 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 147.5K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chen Wang | Board Secretary | — | female |
| Liang Ma | Deputy GM, Chief Financial Officer & Non-Independent Director | — | male |
| Liying Lin | Deputy General Manager | — | female |
| Xiaodong Liu | Chairman & GM | — | male |
| Yongfeng Li | Deputy GM & Non-Independent Director | — | male |
| Zhen Lei Gong | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002568.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
